Literature DB >> 14665375

Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.

Ho-Shiang Huang1, Ming-Chieh Ma, Chau-Fong Chen, Jun Chen.   

Abstract

OBJECTIVES: To determine whether lipid peroxidation plays a role in patients with calcium oxalate kidney stones and to determine the correlation of lipid peroxidation with tubular damage and the major urinary risk factors. We also used the isoenzymes of glutathione S-transferase (GST) to examine which parts of the renal tubules were injured in patients with renal stones.
METHODS: This clinical study included two study groups. Group 1 included 32 normal volunteers, and group 2 included 32 patients with calcium oxalate kidney stones. A 24-hour urine sample was collected from each subject, and the levels of Ca, P, Mg, oxalate, citrate, N-acetyl-beta-glucosaminidase (NAG), beta-galactosidase (GAL), alphaGST, piGST, osteopontin (OPN), thiobarbituric acid-reactive substances (TBARS), and malondialdehyde (MDA) were examined.
RESULTS: Hyperoxaluria, hypocitraturia, and low urinary OPN were the major abnormalities found in the patients with stones. Elevated urinary alphaGST, NAG, and GAL were also noted in the patients with stones; however, urinary piGST showed no statistically significant difference compared with the controls. Urinary TBARS and MDA had statistically significant correlations with alphaGST, GAL, NAG, Ca, and oxalate, but had no correlation with piGST, citrate, OPN, Mg, and P. Urinary citrate had a negative, linear, and statistically significant correlation with alphaGST, GAL, and NAG.
CONCLUSIONS: Lipid peroxidation correlated with hyperoxaluria and renal tubular damage, indicating that hyperoxaluria can induce tubular cell injury and that this injury may be due to the production of free radicals in patients with calcium oxalate stones. Renal tubular damage in patients with stones may be limited to the proximal tubules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14665375     DOI: 10.1016/s0090-4295(03)00764-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  51 in total

1.  Effects of vitamin E ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: evidence of different physiological handling mechanisms.

Authors:  Takalani Theka; Allen Rodgers; Sonja Lewandowski; Dawn Webber; Shameez Allie-Hamdulay
Journal:  Urol Res       Date:  2011-12-03

2.  Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals.

Authors:  Saeed R Khan; Aslam Khan; Karen J Byer
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

3.  Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.

Authors:  Eujin Park; Hee Gyung Kang; Young Hun Choi; Kyoung Bun Lee; Kyung Chul Moon; Hyeon Joo Jeong; Michio Nagata; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2017-04-12       Impact factor: 3.714

4.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.

Authors:  Kemal Sarica; Alper Kafkasli; Fehmi Narter; Oguz Ozturk; Ozgur Yazici; Bilal Hamarat; Cahit Sahin; Bilal Eryildirim
Journal:  Urolithiasis       Date:  2016-06-09       Impact factor: 3.436

5.  Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis.

Authors:  Wipawee Kittikowit; Uraiwan Waiwijit; Chanchai Boonla; Preecha Ruangvejvorachai; Chaowat Pimratana; Chagkrapan Predanon; Supoj Ratchanon; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2014-07-15       Impact factor: 3.436

6.  Protective impact of resveratrol in experimental rat model of hyperoxaluria.

Authors:  Taylan Oksay; Sedat Yunusoğlu; Mustafa Calapoğlu; I Aydın Candan; İbrahim Onaran; Osman Ergün; Alper Özorak
Journal:  Int Urol Nephrol       Date:  2017-02-09       Impact factor: 2.370

7.  Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.

Authors:  Piyaratana Tosukhowong; Chatchai Yachantha; Thosaphol Sasivongsbhakdi; Supoj Ratchanon; Suchada Chaisawasdi; Chanchai Boonla; Kriang Tungsanga
Journal:  Urol Res       Date:  2008-06-17

Review 8.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

9.  Hyperoxaluria-induced tubular ischemia: the effect of verapamil on the limitation of tissue HIF-1 alpha levels in renal parenchyma.

Authors:  Faruk Yencilek; Kemal Sarica; Bilal Eryildirim; Sakip Erturhan; Metin Karakok; Ugur Kuyumcuoglu
Journal:  Int Urol Nephrol       Date:  2009-07-16       Impact factor: 2.370

10.  Taurine protected kidney from oxidative injury through mitochondrial-linked pathway in a rat model of nephrolithiasis.

Authors:  Cheng Yang Li; Yao Liang Deng; Bing Hua Sun
Journal:  Urol Res       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.